Escherichia coli, the yield of functional product for some and Molecular Biology, University College London, Gower Street, antibody fragments can be very low. Sometimes, PCR primerLondon WC1E 6BT, UK induced errors can lead to the expression of non-reactive 3 To whom correspondence should be addressed antibody fragments (McCartney et al., 1995) . Poor expression may also arise from differences in the translation machinery Recombinant antibody fragments directed against cell surand folding pathways of eukaryotic and bacterial cells. For face antigens have facilitated the development of novel example, some nucleotide sequences encoding antibody varitherapeutic agents. As a first step in the creation of cytotoxic able regions were expressed as functional proteins in eukaryotic immunoconjugates, we constructed a single-chain Fv fraghost cells but were unable to express a product in bacteria ment derived from the murine hybridoma OKT3, that (Duenas et al., 1995) . Limiting factors for the efficient producrecognizes an epitope on the ε-subunit of the human CD3 tion of secreted antibody fragments in E.coli appear to be complex. Two amino acid residues were identified that are translocation to the periplasm (Ayala et al., 1995) and folding critical for the high level production of this scFv in in the periplasmic space (Knappik and Plückthun, 1995) . Escherichia coli. First, the substitution of glutamic acid OKT3 is a murine monoclonal antibody (mAb) that recogencoded by a PCR primer at position 6 of V H framework nizes an epitope on the ε-subunit of the human CD3 complex 1 by glutamine led to a more than a 30-fold increase in the (Kung et al., 1979; Van Wauwe et al., 1980; Transy et al. , production of soluble scFv. Second, the substitution of 1989). It has significant clinical utility. OKT3 has been widely cysteine by a serine in the middle of CDR-H3 additionally used to suppress T cells and thereby prevent the rejection of doubled the yield of soluble antibody fragment without transplants (Thistlethwaite et al., 1984; Woodle et al., 1991) . any adverse effect on its affinity for the CD3 antigen. The Conversely, T cell activation and proliferation induced by double mutant scFv (Q,S) proved to be very stable in vitro:
OKT3 have been exploited to expand effector cells ex vivo no loss of activity was observed after storage for 1 month for adoptive cancer immunotherapy (Yannelly et al., 1990) . at 4°C, while the activity of scFv containing a cysteine As well as being used alone, the OKT3 mAb has been used residue in CDR-H3 decreased by more than half. The as a component of bispecific antibodies to retarget cytotoxic results of production yield, affinity, stability measurements T lymphocytes against tumor cells (Nitta et al., 1990 ; Bohlen and analysis of three-dimensional models of the structure et al., 1993) or virus infected cells (Sanna et al., 1995) . suggest that the sixth amino acid influences the correct Recently, humanized versions of the OKT3 mAb have been folding of the V H domain, presumably by affecting a folding expressed in COS cells (Woodle et al., 1992; Adair et al., 1994) . intermediate, but has no effect on antigen binding.
In this paper, we present the first example of the expression Keywords: affinity/anti-human CD3/bacterial expression/ of an OKT3 derived scFv in E.coli. As part of the anti-CD3 single-chain Fv/solubility scFv construction process, the PCR amplified OKT3 V H gene was modified to improve its in vivo folding. Here we analyze the effect of two amino acid residues in the variable heavy Introduction chain domain on the yield, affinity and stability in vitro of In recent years, the use of genetic engineering techniques has anti-CD3 scFv. stimulated the development of antibody-like molecules for therapeutic and diagnostic uses (Winter and Milstein, 1991) .
Materials and methods Unlike glycosylated whole antibodies, fragments such as Fab E.coli strains, plasmids and cell lines and Fv can be easily produced in bacterial cells as functional antigen binding molecules (Better et al., 1988; Skerra and E.coli K12 strain XL1-Blue (Stratagene, La Jolla, CA) was used as the cloning and expression host. For cloning, sequencing Plückthun, 1988) . To stabilize the association of the recombinant V H and V L domains, they have been linked in a singlehybridoma-derived immunoglobulin variable regions and sitespecific mutagenesis, pCR-Script SK(ϩ) (Stratagene) was chain Fv (scFv) construct with a short peptide that connects the carboxy terminus of one domain and the amino terminus used. The scFv gene was assembled and expressed either in the plasmid pOPE51 (Kipriyanov et al., 1994) or in pHOG21 of the other (Bird et al., 1988; Huston et al., 1988) . In comparison with the much larger Fab, F(ab) 2 and IgG forms (Kipriyanov et al., 1996b) . The hybridoma OKT3 producing a monoclonal antibody (IgG2a) against the CD3 human T cell of monoclonal antibody from which they are derived, scFvs have more rapid blood clearance and better tumor penetration antigen has been described previously (Kung et al., 1979; Van Wauwe et al., 1980) . The human CD3-positive acute T cell soluble periplasmic extract as the supernatant and spheroplasts plus the insoluble periplasmic material as the pellet. The leukemia cell line Jurkat and a CD3-negative B cell line JOK-1 were used for flow cytometry.
culture supernatant and the soluble periplasmic extract were combined, clarified by additional centrifugation (30 000 g, Cloning of the variable regions 4°C, 40 min) and passed first through a glass filter of pore Isolation of mRNA from freshly subcloned hybridoma OKT3 size 10-16 µm and then through a Membrex TF filter of pore cells and cDNA synthesis were performed as previously size 0.2 µm (MembraPure, Lörzweiler, Germany). The volume described (Dübel et al., 1994) . DNA coding for the light chain was reduced 10-fold by concentration with Amicon YM 10 variable domain was amplified by PCR using the primers Bi5 membranes (Amicon, Witten, Germany). The concentrated and Bi8 that hybridize to the amino terminal portion of the κ supernatant was clarified by centrifugation and thoroughly chain constant domain and the framework 1 (FR1) region of dialyzed against 50 mM Tris-HCl, 1 M NaCl, pH 7.0 at the κ chain variable domain (Dübel et al., 1994) . For the 4°C. Immobilized metal affinity chromatography (IMAC) was amplification of DNA coding for the heavy chain variable performed at 4°C using a 5 ml column of Chelating Sepharose domain, the primer Bi4 that hybridizes to the amino terminal (Pharmacia) charged with Ni 2ϩ and equilibrated with 50 mM portion of the γ chain constant 1 domain (Dübel et al., 1994) Tris-HCl, 1 M NaCl, pH 7.0 (start buffer). The sample was and Bi3f that hybridizes to the FR1 region of the heavy chain loaded by passing the sample over the column. It was then (Gotter et al., 1995; Kipriyanov et al., 1996b) were used. The washed with 20 column volumes of start buffer followed by 50 µl reaction mixture contained 10 pmol of each primer and start buffer containing 50 mM imidazole until the absorbance 50 ng of hybridoma cDNA, 100 µM each of dNTP, 1ϫVent-(280 nm) of the effluent was minimal (about 30 column buffer (Boeringer Mannheim, Mannheim, Germany), 5 µg volumes). Absorbed material was eluted with 50 mM Tris-BSA and 1 U Vent DNA polymerase. 30 cycles of 1 min at HCl, 1 M NaCl, 250 mM imidazole, pH 7.0. After buffer 95°C, 1 min at 55°C and 2 min at 75°C were carried out in a exchange to 50 mM MES, pH 6.0, the protein was further thermocycler. The amplified DNA was purified with a QIApurified on a Mono S ion-exchange column (Pharmacia). The quick PCR Purification Kit (Qiagen, Hilden, Germany) and purified scFv was dialyzed into PBS (15 mM sodium phosphate, blunt end ligated into an SrfI digested pCR-Script SK(ϩ) 0.15 M NaCl, pH 7.4). For long-term storage, scFv were (Stratagene) for dideoxy sequencing (Sanger et al., 1977) and frozen in presence of BSA (final concentration 10 mg/ml) and site-specific mutagenesis.
kept at -80°C, as recommended (Kipriyanov et al., 1995) .
Construction of plasmids encoding scFv
Isolation of scFv from inclusion bodies of bacteria transformed with plasmid pOPE51 was performed essentially as The linker used in this study was a 17 amino acid tag-linker that includes a tubulin epitope recognized by mAb YOL1/34 described previously (Kipriyanov et al., 1996a) . (Breitling et al., 1991) . DNA coding for the variable domains SDS-PAGE and Western blot analysis of OKT3 was inserted into pOPE51 (Kipriyanov et al., 1994) SDS-PAGE was carried out according to Laemmli (1970) in two cloning steps using NcoI/HindIII for the heavy-chain under reducing conditions. Immunoblot analysis using anti DNA and EcoRV/BamHI for the light-chain DNA. The whole c-myc mouse mAb 9E10 (Cambridge Research Biochemicals, scFv gene was recloned in pHOG21 (Kipriyanov et al., 1996b) Cambridge, UK) was performed as described previously as a NcoI/BamHI DNA fragment. (Kipriyanov et al., 1994) .
Construction of anti-CD3 mutants
Analyses of scFv stability Mutations were generated in the V H domain derived from For stability analyses, scFv preparations were stored at 4°C at OKT3 by site-specific mutagenesis according to Kunkel et al. a concentration 50 µg/ml in PBS for 1 month. The activities (1987) . The amino acid substitution of Cys at position H100A of samples after storage were determined by flow cytometry. by Ser and of Glu at position H6 by Gln was achieved using Flow cytometry either primer SK1 5Ј-GTAGTCAAGGCTGTAATGATCATC or SK2 5Ј-GCCCCAGACTGCTGCAGCTGCAC or both.
We incubated 5ϫ10 5 CD3 ϩ Jurkat or CD3 -JOK-1 cells in 50 µl RPMI 1640 medium (Gibco BRL, Eggenstein, Germany) E.coli expression and purification of scFv fragments supplemented with 10% fetal calf serum (FCS) and 0.1% XL1-Blue E.coli cells (Stratagene) transformed with the scFv sodium azide (referred to as complete medium) with 100 µl expression plasmid pHOG21 were grown overnight in 2ϫYT of a sample containing scFv for 45 min on ice. After washing medium with 50 µg/ml ampicillin and 100 mM glucose with complete medium, the cells were incubated with 100 µl (2ϫYT GA ) at 37°C. Dilutions (1:50) of the overnight cultures of 10 µg/ml anti c-myc mAb 9E10 (ICI Biochemicals) in the in 2ϫYT GA were grown as flask cultures at 37°C with shaking same buffer for 45 min on ice. After a second washing cycle, at 200 r.p.m. When cultures reached OD 600 ϭ 0.8, bacteria the cells were incubated with 100 µl of FITC-labeled goat were pelleted by centrifugation at 1500 g for 10 min and 20°C
anti-mouse IgG (Gibco BRL) under the same conditions as and resuspended in the same volume of fresh 2ϫYT medium before. The cells were then washed again and resuspended in containing 50 µg/ml ampicillin and 0.4 M sucrose. IPTG was 100 µl of a 1 µg/ml solution of propidium iodide (Sigma, added to a final concentration of 0.1 mM and growth was Deisenhofen, Germany) in complete medium to exclude dead continued at room temperature (20-22°C) for 20 h. The cells cells. The relative fluorescence of stained cells was measured were harvested by centrifugation at 5000 g for 10 min and using a FACScan flow cytometer (Becton Dickinson, Mountain 4°C. The culture supernatant was retained and kept on ice. To View, CA). isolate soluble periplasmic proteins, the pelleted bacteria were Measurement of binding affinity resuspended in 5% of the initial volume of ice-cold 50 mM Tris-HCl, 20% sucrose, 1 mM EDTA, pH 8.0. After a 1 h Affinities were derived either from the FACScan analysis of direct binding of scFv to Jurkat cells as described by Chamow incubation on ice with occasional stirring, the spheroplasts were centrifuged at 30 000 g for 30 min and 4°C leaving the et al. (1994) or from a competitive inhibition assay. In the latter case, increasing concentrations of scFv were added to a subsaturating concentration of FITC-labeled mAb OKT3 (7.4 nM) and were incubated with Jurkat cells as described above. Fluorescence intensities of stained cells were measured as described above. Binding affinities were calculated according to the following equation derived from that of Schodin and Kranz (1993) :
where I is the unlabeled inhibitor (scFv), is the concentration of FITC-labeled mAb OKT3, K a(OKT3) is the binding affinity of mAb OKT3 (1.2ϫ10 9 M -1 ; Adair et al., 1994) and IC 50 is the concentration of inhibitor that yields 50% inhibition of binding. extracts isolated from shake-tube mini-cultures (5 ml). Culture supernatants were concentrated 20-fold using an Ultrafree-15 Results Biomax-10 centrifugal filter device (Millipore, Bedford, MA, Modification of PCR amplified OKT3 V H gene USA) and dialyzed into PBS. The periplasmic extracts from
Determination of the yield of soluble antibody fragments
The V region genes of the murine monoclonal antibody OKT3 cell pellets were prepared as described previously (Kipriyanov (Van Wauwe et al., 1980) were amplified by PCR from a cDNA et al., 1996b). For each scFv variant, three independent preparation using two pairs of highly degenerate primers. Ten expression cultures were used. The concentrations of functional clones of each amplified V H and V L gene were sequenced and recombinant antibody fragments were determined from the found to be identical. All the analyzed heavy chain variable fluorostaining of Jurkat cells using samples of periplasmic regions contained QVQLQE as the N-terminal sequence. This preparations and concentrated culture medium by the interpolaregion was encoded by the 5Ј primer Bi3f that contained a tion of their mean fluorescence intensities on the standard degenerate codon corresponding either to glutamic acid or curves obtained with purified scFv of known concentration.
glutamine residue at position 6 (Gotter et al., 1995; Kipriyanov At least four dilutions of samples were used for calculations. et al., 1996b) . The OKT3 scFv gene was assembled in the Molecular modeling plasmid pOPE51 (Kipriyanov et al., 1994) and expressed in E.coli. The resulting recombinant scFv product contained an Modeling was performed using AbM (Oxford Molecular, unpaired cysteine residue near to its C-terminus that was Oxford, UK). The framework was built by homology using specially introduced for making bivalent antibodies by HyHEL-5 (Sheriff et al., 1987) for the parent light chain and 36-chemical conjugation or for site-specific biotinylation 71 (Strong et al., 1991) for the heavy chain. The complementarity (Kipriyanov et al., 1994) . determining regions (CDR) L1, L2, L3, H1 and H2 were built FACScan analysis demonstrated no binding of scFv-OKT3 using canonical classes as proposed by Chothia et al. (1989) isolated from periplasmic inclusion bodies (Kipriyanov et al., ϭ Class 1, CDR-L2 ϭ Class 1, CDR-L3 ϭ Class 1, 1994; Kipriyanov et al., 1995) to CD3-positive Jurkat cells CDR-H1 ϭ Class 1, CDR-H2 ϭ Class 2) while CDR-H3 was (data not shown). A detailed analysis of the predicted structure built using the CAMAL algorithm (Martin et al., 1989) .
based on the OKT3 V domain sequences allowed us to identify AbM sometimes has problems with junction regions where two amino acid residues in the V H domain that might be loops are spliced on to the framework. This can result in critical for the activity of this recombinant antibody (Figure trigonal planar or D-amino acids at these junction sites. This 1). First, a comparison with the OKT3 cDNA sequence (Adair occurred for residue H102 and this residue was rebuilt manually et al., 1994) showed that position 6 of FR1 was occupied by as an L-amino acid.
glutamine but not by glutamic acid as in the PCR amplification Other methods product. Furthermore, the consensus sequences of the Kabat Protein concentrations were determined by the Bradford dyedatabase demonstrated that the cloned V H gene fragment binding assay (Bradford, 1976) using the Bio-Rad protein belongs to mouse immunoglobulin subgroup IIb (Kabat et al., assay kit (Bio-Rad Laboratories, Munich, Germany). The 1991), in which 92% of the members have Q in position 6. concentrations of purified scFv were calculated from the A 280 Second, the OKT3 V H domain was found to contain a cysteine values using the extinction coefficient ε 1 mg/ml ϭ 1.84 derived residue in the CDR-H3 which could interfere with folding by from the Trp, Tyr and Phe content of the molecule using disrupting normal disulfide bonding, or might be oxidized DNAidϩ1.8 Sequence Editor for Macintosh (F.Dardel and during IMAC on an Ni column under denaturing conditions P.Bensoussan, Laboratoire de Biochimie, Ecole Polytechnique, (Kipriyanov et al., 1994) . Therefore, we performed site-specific Palaiseau, France). Analytical gel filtration of the scFv preparamutagenesis of the V H gene to substitute E6 by Q and C100A tion was performed in PBS using a Superdex 75 HR10/30
[numbering scheme of Kabat et al. (1991) ] by S. This doublecolumn (Pharmacia). The sample volume and flow rate were mutant scFv-dmOKT3 (Q,S) demonstrated strong binding to 200 µl and 0.5 ml/min, respectively. For calibration of the CD3-positive Jurkat cells and no interaction with CD3-negative column, a Low Molecular Weight Gel Filtration Calibration JOK-1 cells when purified from inclusion bodies (data not shown). Kit (Pharmacia) was used.
Construction and expression of anti-CD3 scFv mutants
To clarify how the amino acid changes described above contribute to the activity of the anti-CD3 scFv, we investigated four different scFv variants: a variant containing E6 and C100A that was amplified from hybridoma cDNA by PCR (E,C), a variant corresponding to the cDNA sequence published for OKT3 (Q,C; Adair et al., 1994) and two variants containing Ser instead of Cys at V H position 100A (E,S and Q,S).
To avoid working with inclusion bodies, which have to be refolded and to prevent vector-derived C-terminal unpaired cysteines from affecting the scFv properties (e.g. possible formation of an additional intramolecular disulfide bond with Cys-100A or scFv dimerization), we chose the plasmid pHOG21 for expressing the mutated scFv genes (Figure 2A) . The bacterial pHOG21 expression vector was designed for the high-level production of soluble recombinant antibody fragments in E.coli (Kipriyanov et al., 1996b) . The antibody V H fragment is preceded by a pelB leader sequence for secretion of recombinant antibody into the periplasmic space. The C-terminus of the V H domain and N-terminus of the V L domain are joined by a flexible 17 amino acid tag-linker that includes a tubulin epitope recognized by mAb YOL1/34 (Breitling et al., 1991) . A short peptide tag containing an epitope of the proto-oncogene c-myc recognized by mAb 9E10 (Evan et al., 1985) is located at the C-terminus of the V L domain followed by six histidine residues to facilitate the isolation of recombinant antibody fragments by IMAC. The sequence of the OKT3 derived scFv assembled in the plasmid pHOG21 is shown in Figure 2B with the mutations at amino acid positions 6 and 100A of the heavy chain indicated.
Recently, we showed that the addition of 0.4 M sucrose to the growth medium gives a 15-25-fold increase in the yield of soluble scFv for bacterial shake-tube cultures and an 80-150-fold increase for shake-flask cultures . We also found that the scFv could be made to accumulate in the periplasm or be secreted into the medium by simply changing the incubation conditions and the concentration of the inducer. Therefore, to obtain higher yields of soluble anti-CD3 antibody fragments, we incubated induced E.coli cells in the presence of 0.4 M sucrose. Western blot analysis of cell pellets and periplasmic extracts of bacterial cultures expressing the four variants of OKT3 derived scFv demonstrated substantial differences in the ratio of soluble and total scFv ( Figure  3 ). While the total amount of recombinant product found in the cell pellet seemed to be equal for all scFv variants, much less soluble scFv was found for variants containing Glu at performed a large-scale isolation of scFv using shake-flask bacterial cultures in the presence of 0.4 M sucrose. Under charged Chelating Sepharose column. After washing the these conditions, we previously found that most of the secreted column with buffer containing 50 mM imidazole, the bound scFv was released into the medium .
scFv was eluted with 250 mM imidazole as a single peak in The supernatant and periplasmic content of the induced bac-2.5 column volumes. This purification procedure allowed us to isolate scFv in one step with a purity of about 95% (Figure terial culture was concentrated and passed through an Ni 2ϩ Fig. 3 . Western blot analysis of cell pellets and periplasmic extracts from E.coli clones expressing different anti-CD3 scFv variants. Lanes: 1, 3, 5, 7, total cell lysate from induced bacteria corresponding to 100 µl of culture; 2, 4, 6, 8, periplasmic extracts corresponding to 180 µl of culture. The scFv were detected using mAb 9E10 recognizing the C-terminal c-myc epitope. As a control, 1 µg of pure scFv-dmOKT3 isolated from inclusion bodies was used. The positions of molecular mass markers are shown on the left. 5A). The main contaminant present in samples of scFv purified by IMAC has recently been identified as an E.coli metalbinding 27 kDa WHP protein ). An analysis of its amino acid composition showed that the WHP protein has an isoelectric point (Ia) of 5.16; anti-CD3 scFv variants were found to be more basic (the calculated Ia was between 7.27 for the E,C and 7.52 for the Q,S variant). This charge difference allowed us to purify the recombinant antibody fragments to homogeneity by ion-exchange chromatography on a Mono S column ( Figure 5B ). Analytical gel-filtration on a Superdex 75 column demonstrated that all the isolated scFv preparations consisted only of monomers (data not shown). Affinity and stability measurements Our attempts to use radioiodinated scFv preparations for measuring the direct binding of recombinant antibodies to CD3-positive Jurkat cells were unsuccessful. Unfortunately, iodination using chloramine-T yielded an inactive product for both anti-CD3 scFv and Fab fragment prepared from mAb OKT3 (data not shown). It is possible that iodination blocked tyrosine residues in the CDR regions that may be important for antigen-binding ( Figure 2B ). We therefore employed two different non-radioactive approaches based on flow cytometry (Bohn, 1980) that do not require any modification of the protein.
In the first approach, recombinant antibody fragments were incubated with cells as in a standard radioprotein binding assay, except that an anti-c-myc mAb and fluorescent antimouse IgG reagent were used to detect the amount of bound et al., 1994) .
The binding of scFv preparations was measured using human Jurkat cells as a source of naturally expressed cell bound increased amounts of scFv was observed that seems to reach a plateau at higher concentrations ( Figure 6A ). On the basis CD3ε. Binding to CD3-negative JOK-1 cells was used as a negative control. The results of fluorostaining of Jurkat cells of fluorescence measurements at different concentrations of added scFv, typical Scatchard curves were generated from displayed in Figure 4B demonstrate that the same concentrations of different scFv variants yield similar fluorescence which K a values were derived (data not shown). In a second approach, the binding efficiency of anti-CD3 (slightly higher values were obtained for variants containing Gln at position 6). A pattern of increased fluorescence with scFv variants to Jurkat T cells was investigated by competition with FITC-labeled mAb OKT3. The data presented in Figure  probably because of a higher tendency for such antibody 6B demonstrate that the OKT3 derived scFv Q,C, E,S and fragments to aggregate and/or for oxidation of unpaired cyst-Q,S variants competed similarly, all at~100 times the conceneine residues during storage. No proteolytic degradation during tration of the intact IgG OKT3.
storage was detected for any of the examined scFv variants Analysis of the stability of anti-CD3 scFv variants after (data not shown). storage in PBS for 1 month at 4°C demonstrated a substantial Analysis of expression yields loss of antigen-binding activity for scFv containing Cys in
To study the influence of positions H6 and H100A on the CDR-H3 (Figure 7) . production levels of soluble scFv fragments, we analyzed the Table I summarizes the results of the affinity and stability antigen binding activities of periplasmic extracts and the measurements. The apparent affinity values obtained for all concentrated culture medium of bacteria expressing scFv E,C, the scFv variants proved to be quite close, indicating (i) only Q,C, E,S and Q,S variants. The expression yield data presented a slight effect of the sixth amino acid on the antigen binding in Table I demonstrate that a single amino acid substitution of and (ii) that the replacement of Ser for Cys in the middle of E6 by Q yields more than a 30-fold increase in soluble scFv CDR-H3 does not disturb the antigen-antibody complex. Both product. In contrast, the single exchange of C100A by S led the glutamic acid at position H6 and especially the cysteine at position of H100A led to a decreased stability of the scFv, to a more moderate twofold increase in soluble scFv. These effects were cumulative: the total yield of the Q,S variant was not always yield a gene with naturally occurring codons in the primer region (McCartney et al., 1995) . It is therefore often 66-fold higher than that for the E,C scFv variant (Table I) . For all the examined variants, a small proportion of the not possible to know which codons occur naturally if, as in our case, the DNA sequence was not then available. For functional soluble scFv was found to be released into the culture medium.
example, the same set of primers resulted either in Glu or Gln in H6 after amplification of the V H gene of an antibody against anti-human CD19 (Kipriyanov et al., 1996b) . Regarding the Discussion significance of this position, there was no indication in the Recombinant antibody fragments directed against cell surface literature that it may be critical for bacterially expressed antigens can provide useful components for the development antibody fragments. of therapeutic agents. To target cytotoxic effector T cells to a
To improve the properties of the recombinant antibody tumor site, we have constructed an anti-human CD3 singlefragment, we focused on the amino acid residues which are chain antibody by PCR amplification of the immunoglobulin structurally uncommon for the V H subgroup IIb: glutamic acid variable domain genes from cDNA of the hybridoma OKT3.
at the position H6 of FR1 and a cysteine in the middle of the Expression of the assembled scFv gene in E.coli yielded a CDR-H3 loop. Site-specific mutagenesis and a change of non-functional product after refolding from inclusion bodies.
expression system (soluble secreted scFv versus inclusion In general, the primers we and other workers use for bodies) allowed us to clarify their influence on the production amplifying V genes from hybridoma cDNAs are designed to of a functional scFv antibody fragment. match all the known sequences of immunoglobulin genes.
We demonstrated that a single amino acid substitution of E However, PCR amplification using degenerate primers does by Q at position 6 of the heavy chain resulted in a 30-fold increase in soluble scFv product and significantly increased the stability of the recombinant molecule during storage. However, this substitution had very little effect on the affinity (scFv containing Q had affinity constants about 1.5 times higher than variants with E). This slight difference may be explained by the possible difference in the percentage of functional scFv (Kipriyanov et al., 1994) . We can therefore conclude that the sixth amino acid influences the correct folding of the V H domain, perhaps by affecting some folding intermediate, but it has little or no effect on antigen binding. This conclusion was supported by computational molecular modeling. Examination of the residues which surround position 6 of the heavy chain in the three-dimensional model reveals no reason why a Glu or Gln residue should have any significant effect on the conformations of the CDRs (Figure 1 ). It is not clear how Glu may effect the folding of the scFv fragment in the bacterial environment because very little is known about this process. Attempts have been made to prevent the side reaction of aggregation by overexpressing some known enzymes of the E.coli folding machinery such as the GroES/L chaperones, disulfide-isomerase and proline-cistrans-isomerase (Knappik et al., 1993; Duenas et al., 1994) . is accumulating that the primary sequence of the antibody plays a decisive role in the efficiency of folding in a bacterial refold several antibody fragments (Kipriyanov et al., 1994; Gotter et al., 1995) and a more complex scFv::streptavidin environment (Carter et al., 1992; Knappik and Plückthun, 1995) . Our own results lead to a similar conclusion. The amino fusion protein (Kipriyanov et al., 1996a) did not lead to the formation of an active scFv-E,C variant. These results point acid H6 influences not only the folding efficiency but also the stability of the correctly folded scFv.
to limitations in the folding strategy in vitro compared with in vivo and indicate how such problems can be overcome. The single exchange of Cys at position H100A by Ser also led to a twofold increase in soluble scFv. Three residues before
In conclusion, we have constructed a modified version of an anti-human CD3 scFv antibody fragment with improved the start of CDR-H3 is a conserved cysteine at position H92 which forms a structural disulfide bond with position H22.
stability in vitro and increased production level in bacteria. This molecule may be particularly useful for the creation of Thus, having another Cys nearby (at H100A) could easily allow mis-folding where H100A instead of H92 is involved recombinant cytotoxic immunoconjugates. in forming the disulfide bond with H22, thereby generating a mis-folded, insoluble and non-functional product. Analogously,
